Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Boehringer Ingelheim
Chinese Patent Office
Fuji
AstraZeneca
Healthtrust
Express Scripts
Chubb

Generated: August 20, 2018

DrugPatentWatch Database Preview

Pioglitazone hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for pioglitazone hydrochloride and what is the scope of pioglitazone hydrochloride patent protection?

Pioglitazone hydrochloride is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Accord Hlthcare, Aurobindo Pharma Ltd, Breckenridge Pharm, Cipla Ltd, Dr Reddys Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Prinston Inc, Puracap Pharm Llc, Sandoz, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for pioglitazone hydrochloride. Thirty suppliers are listed for this compound. There are two tentative approvals for this compound.

Synonyms for pioglitazone hydrochloride
(+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride
[(+-)-5-[[4-[4-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] monohydrochloride
[5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride
025P468
112529-15-4
127676-30-6
2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)-
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, monohydrochloride
2,4-thiazolidinedione,5-((4-(2-(5-ehtyl-2-pyridinyl)ethoxy)phenyl)methyl)-monohydrochloride
5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, hcl
5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride
5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride
5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hcl
5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hydrochloride
5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride
5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, hydrochloride
5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride
5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione hydrochloride
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride
5-[4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl]-thiazolidine-2,4-dione hydrochloride
5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione HCl
5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride
A-2403
A802593
AA-10090
AB0013914
AB1009260
AC-1037
AC1L1THE
AC1Q6GK5
ACT04238
AK-50391
AKOS015844016
AM20061770
AN-15335
ANW-42027
BB_SC-4137
BC204340
BCP0726000151
BR-50391
C19H20N2O3S.HCl
C19H21ClN2O3S
CAS-112529-15-4
CCG-100931
CCG-39097
CHEBI:8229
CHEMBL1715
CP0139
CPD000469167
CS-2235
CTK8B3228
D00945
DSSTox_CID_24203
DSSTox_GSID_44203
DSSTox_RID_80116
DTXSID3044203
FT-0082357
FT-0601607
GHUUBYQTCDQWRA-UHFFFAOYSA-N
HMS1922L05
HY-14601
I06-0413
I868
J10107
KS-00000IO7
KS-1186
LS-151328
LS-172192
MCULE-1259842295
MFCD04975446
MLS001306462
MLS001401386
MolPort-003-666-558
MolPort-027-851-177
NC00181
NCGC00095131-01
NCGC00095131-02
NCGC00163128-08
NCGC00254492-01
P1901
Pioditazone hydrochloride
Pioglitazone (hydrochloride)
Pioglitazone for system suitability, European Pharmacopoeia (EP) Reference Standard
Pioglitazone HCl
Pioglitazone hydrochloride (Actos)
Pioglitazone hydrochloride (JP17/USP)
Pioglitazone hydrochloride [USAN:USP]
Pioglitazone hydrochloride [USAN]
Pioglitazone hydrochloride, >=98% (HPLC)
Pioglitazone hydrochloride, European Pharmacopoeia (EP) Reference Standard
Pioglitazone hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur
Pioglitazone hydrochloride, United States Pharmacopeia (USP) Reference Standard
pioglitazone, hydrochloride
Piomed
Q-201584
RTR-001112
s2046
SAM001246600
SC-19064
SCHEMBL21843
SMR000469167
SPECTRUM1504401
ST2411660
TL8000362
Tox21_111440
Tox21_111440_1
Tox21_300584
TR-001112
U-72107A
U-72107E
Tentative approvals for PIOGLITAZONE HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up15MGTABLET; ORAL
➤ Sign Up➤ Sign Up45MGTABLET; ORAL
➤ Sign Up➤ Sign Up30MGTABLET; ORAL

US Patents and Regulatory Information for pioglitazone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 207806-001 Apr 17, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Breckenridge Pharm PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078472-001 Feb 13, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078383-003 Mar 12, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cipla Ltd PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 076798-001 Oct 26, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 200268-002 Feb 13, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 202456-003 Feb 13, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Torrent Pharms Ltd PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 091298-002 Feb 13, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for pioglitazone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-003 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-001 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-002 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-001 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-001 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-003 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa ACTOS pioglitazone hydrochloride TABLET;ORAL 021073-002 Jul 15, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Baxter
Argus Health
Federal Trade Commission
Healthtrust
Fish and Richardson
Deloitte
Covington
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.